Brick & Kyle, Associates - GALENA BIOPHARMA INC ownership

GALENA BIOPHARMA INC's ticker is GALE and the CUSIP is 363256504. A total of 64 filers reported holding GALENA BIOPHARMA INC in Q4 2016. The put-call ratio across all filers is 0.17 and the average weighting 0.0%.

Quarter-by-quarter ownership
Brick & Kyle, Associates ownership history of GALENA BIOPHARMA INC
ValueSharesWeighting
Q1 2017$0370.0%0.00%
Q4 2016$0370.00%
Other shareholders
GALENA BIOPHARMA INC shareholders Q4 2016
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 2,465,860$1,504,0000.08%
DAFNA Capital Management LLC 46,145$28,0000.02%
EQUITEC SPECIALISTS, LLC 174,500$106,0000.02%
Nine Chapters Capital Management LLC 21,000$13,0000.02%
Airain ltd 86,248$53,0000.00%
Tower Research Capital LLC (TRC) 55,949$34,0000.00%
EQUITEC SPECIALISTS, LLC 22,500$14,0000.00%
TWO SIGMA SECURITIES, LLC 12,886$8,0000.00%
QUADRANT CAPITAL GROUP LLC 5,094$3,0000.00%
Renaissance Technologies 1,600,275$976,0000.00%
View complete list of GALENA BIOPHARMA INC shareholders